Iranian Journal of Pediatrics

Published by: Kowsar
Crossmark
Uncorrected Proof scheduled for 29 (4)

Alterations in Serum Lead Levels Following Packed Red Blood Cells Transfusions to Preterms Admitted to Neonatal Intensive Care Unit at Cairo University Pediatric Hospital

Shaimaa A. M. Abd El Fatah 1 , * , John Rene Labib 2 , Nancy A. S. Gomaa 2 , Sally Kamal Ibrahem 2 and Mona Adel Soliman Attia 1 , 2
Authors Information
1 Public Health Department, Faculty of Medicine, Cairo University, Cairo, Egypt
2 Pediatrics Department, Faculty of Medicine, Cairo University, Cairo, Egypt
Article information
  • Iranian Journal of Pediatrics: In Press (In Press); e90977
  • Published Online: July 3, 2019
  • Article Type: Research Article
  • Received: February 23, 2019
  • Revised: April 19, 2019
  • Accepted: May 25, 2019
  • DOI: 10.5812/ijp.90977

To Cite: Abd El Fatah S A M, Labib J R, Gomaa N A S, Ibrahem S K, Soliman Attia M A. Alterations in Serum Lead Levels Following Packed Red Blood Cells Transfusions to Preterms Admitted to Neonatal Intensive Care Unit at Cairo University Pediatric Hospital, Iran J Pediatr. Online ahead of Print ; In Press(In Press):e90977. doi: 10.5812/ijp.90977.

Abstract
Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Zubairi H, Visintainer P, Fleming J, Richardson M, Singh R. Lead exposure in preterm infants receiving red blood cell transfusions. Pediatr Res. 2015;77(6):814-8. doi: 10.1038/pr.2015.53. [PubMed: 25760547].
  • 2. Wilhelm M, Heinzow B, Angerer J, Schulz C. Reassessment of critical lead effects by the German Human Biomonitoring Commission results in suspension of the human biomonitoring values (HBM I and HBM II) for lead in blood of children and adults. Int J Hyg Environ Health. 2010;213(4):265-9. doi: 10.1016/j.ijheh.2010.04.002. [PubMed: 20493765].
  • 3. Central Agency For Public Mobilization And Statistics (CAPMAS). Central statistical year book. 2017. Available from: http://www.capmas.gov.eg.
  • 4. Healey N, Jones-Otazo H, Walker M, Knafla A. Toxicological Review and recommended toxicological reference values for environmental lead exposure in canada. Report prepared for health Canada, healthy environments and consumer safety branch, environmental health bureau, Ottawa, ON. 2010. Available from: https://www.paho.org/hq/index.php?option=com_docman&task=doc...en.
  • 5. Collard KJ. Transfusion related morbidity in premature babies: Possible mechanisms and implications for practice. World J Clin Pediatr. 2014;3(3):19-29. doi: 10.5409/wjcp.v3.i3.19. [PubMed: 25254181]. [PubMed Central: PMC4162441].
  • 6. Elabiad MT, Christensen M. Changes in premature infant mercury and lead blood levels after blood transfusions. Am J Perinatol. 2014;31(10):863-8. doi: 10.1055/s-0033-1361936. [PubMed: 24347256].
  • 7. Guillen U, Cummings JJ, Bell EF, Hosono S, Frantz AR, Maier RF, et al. International survey of transfusion practices for extremely premature infants. Semin Perinatol. 2012;36(4):244-7. doi: 10.1053/j.semperi.2012.04.004. [PubMed: 22818544]. [PubMed Central: PMC3579510].
  • 8. Josephson CD, Mondoro TH, Ambruso DR, Sanchez R, Sloan SR, Luban NL, et al. One size will never fit all: The future of research in pediatric transfusion medicine. Pediatr Res. 2014;76(5):425-31. doi: 10.1038/pr.2014.120. [PubMed: 25119336]. [PubMed Central: PMC4408868].
  • 9. Keir A, Pal S, Trivella M, Lieberman L, Callum J, Shehata N, et al. Adverse effects of small-volume red blood cell transfusions in the neonatal population. Syst Rev. 2014;3:92. doi: 10.1186/2046-4053-3-92. [PubMed: 25143009]. [PubMed Central: PMC4149676].
  • 10. Joint FAO/WHO Expert Committee on Food Additives. Evaluation of certain food additives and contaminants. Geneva; 2010. Available from: http://whqlibdoc.who.int/trs/WHO_TRS_960_eng.pdf.
  • 11. Lavoie J. Blood transfusion risks and alternative strategies in pediatric patients. Paediatr Anaesth. 2011;21(1):14-24. doi: 10.1111/j.1460-9592.2010.03470.x. [PubMed: 21155923].
  • 12. Bearer CF, O'Riordan MA, Powers R. Lead exposure from blood transfusion to premature infants. J Pediatr. 2000;137(4):549-54. doi: 10.1067/mpd.2000.108273. [PubMed: 11035837].
  • 13. Agency for Toxic Substances and Disease Registry. Lead toxicity.What is the biological fate of lead. 2007. Available from: http://www.atsdr.cdc.gov/csem/csem.
  • 14. Polin RA, Fox WW, Abman SH. Fetal and neonatal physiology. 3rd ed. Philadelphia, PA: Saunders Co; 2004. 1263 p.
  • 15. Askenazi DJ, Koralkar R, Patil N, Halloran B, Ambalavanan N, Griffin R. Acute Kidney Injury Urine Biomarkers in Very Low-Birth-Weight Infants. Clin J Am Soc Nephrol. 2016;11(9):1527-35. doi: 10.2215/CJN.13381215. [PubMed: 27471253]. [PubMed Central: PMC5012492].
  • 16. Greenberg JH, Parikh CR. Biomarkers for diagnosis and prognosis of AKI in children: one size does not fit all. Clin J Am Soc Nephrol. 2017;12(9):1551-7. doi: 10.2215/CJN.12851216. [PubMed: 28667085]. [PubMed Central: PMC5586584].
  • 17. Bardallo Cruzado L, Perez Gonzalez E, Martinez Martos Z, Bermudo Guitarte C, Granero Asencio M, Luna Lagares S, et al. Serum cystatin C levels in preterm newborns in our setting: Correlation with serum creatinine and preterm pathologies. Nefrologia. 2015;35(3):296-303. doi: 10.1016/j.nefro.2015.05.004. [PubMed: 26299173].
  • 18. Kandasamy Y, Rudd D, Smith R. The relationship between body weight, cystatin C and serum creatinine in neonates. J Neonatal Perinatal Med. 2017;10(4):419-23. doi: 10.3233/NPM-171719. [PubMed: 29286938].
  • 19. Eder AF, Chambers LA. Noninfectious complications of blood transfusion. Arch Pathol Lab Med. 2007;131(5):708-18. doi: 10.1043/1543-2165(2007)131[708:NCOBT]2.0.CO;2. [PubMed: 17488156].
  • 20. Elabiad MT, Hook RE. Lead content of blood transfusions for extremely low-birth-weight infants. Am J Perinatol. 2013;30(9):765-70. doi: 10.1055/s-0032-1332803. [PubMed: 23322387].
  • 21. Lee JY, Kim HS, Jung E, Kim ES, Shim GH, Lee HJ, et al. Risk factors for periventricular-intraventricular hemorrhage in premature infants. J Korean Med Sci. 2010;25(3):418-24. doi: 10.3346/jkms.2010.25.3.418. [PubMed: 20191041]. [PubMed Central: PMC2826744].
  • 22. Zhang H, Fang J, Su H, Chen M. Risk factors for bronchopulmonary dysplasia in neonates born at ≤ 1500 g (1999-2009). Pediatr Int. 2011;53(6):915-20. doi: 10.1111/j.1442-200X.2011.03399.x. [PubMed: 21605281].
  • 23. Kanias T, Gladwin MT. Nitric oxide, hemolysis, and the red blood cell storage lesion: Interactions between transfusion, donor, and recipient. Transfusion. 2012;52(7):1388-92. doi: 10.1111/j.1537-2995.2012.03748.x. [PubMed: 22780890]. [PubMed Central: PMC3855012].
  • 24. Roseff SD. Neonatal transfusion practice: should our policies mature with our patients? Transfusion. 2011;51(5):908-13. doi: 10.1111/j.1537-2995.2011.03150.x. [PubMed: 21545590].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments